colin Watts
colin Watts
Professor of Neurosurgery University of Birmingham
Verified email at
Cited by
Cited by
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
A Sottoriva, I Spiteri, SGM Piccirillo, A Touloumis, VP Collins, JC Marioni, ...
Proceedings of the National Academy of Sciences 110 (10), 4009-4014, 2013
JA Swanson, C Watts
Trends in cell biology 5 (11), 424-428, 1995
Capture and processing of exogenous antigens for presentation on MHC molecules
C Watts
Annual review of immunology 15 (1), 821-850, 1997
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
M Weller, M Van Den Bent, JC Tonn, R Stupp, M Preusser, ...
The lancet oncology 18 (6), e315-e329, 2017
Enhanced detection of circulating tumor DNA by fragment size analysis
F Mouliere, D Chandrananda, AM Piskorz, EK Moore, J Morris, ...
Science translational medicine 10 (466), eaat4921, 2018
Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling
MA West, RPA Wallin, SP Matthews, HG Svensson, R Zaru, HG Ljunggren, ...
Science 305 (5687), 1153-1157, 2004
Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells.
MA West, MS Bretscher, C Watts
The Journal of cell biology 109 (6), 2731-2739, 1989
Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages
CC Norbury, LJ Hewlett, AR Prescott, N Shastri, C Watts
Immunity 3 (6), 783-791, 1995
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
S Palfi, JM Gurruchaga, GS Ralph, H Lepetit, S Lavisse, PC Buttery, ...
The Lancet 383 (9923), 1138-1146, 2014
Constitutive macropinocytosis allows TAP‐dependent major histocompatibility compex class I presentation of exogenous soluble antigen by bone marrow‐derived dendritic cells
CC Norbury, BJ Chambers, AR Prescott, HG Ljunggren, C Watts
European journal of immunology 27 (1), 280-288, 1997
The coated pit and macropinocytic pathways serve distinct endosome populations
LJ Hewlett, AR Prescott, C Watts
The Journal of cell biology 124 (5), 689-703, 1994
An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation
B Manoury, EW Hewitt, N Morrice, PM Dando, AJ Barrett, C Watts
Nature 396 (6712), 695-699, 1998
Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase
JM Chen, PM Dando, ND Rawlings, MA Brown, NE Young, RA Stevens, ...
Journal of Biological Chemistry 272 (12), 8090-8098, 1997
Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells
MA West, JM Lucocq, C Watts
Nature 369 (6476), 147-151, 1994
Longitudinal molecular trajectories of diffuse glioma in adults
FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ...
Nature 576 (7785), 112-120, 2019
The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules
C Watts
Nature immunology 5 (7), 685-692, 2004
Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation
MA West, AR Prescott, EL Eskelinen, AJ Ridley, C Watts
Current Biology 10 (14), 839-848, 2000
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
E Le Rhun, M Weller, D Brandsma, M Van den Bent, E De Azambuja, ...
Annals of oncology 28, iv84-iv99, 2017
Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments
PA Reid, C Watts
Nature 346 (6285), 655-657, 1990
Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants.
PD Simitsek, DG Campbell, A Lanzavecchia, N Fairweather, C Watts
The Journal of experimental medicine 181 (6), 1957-1963, 1995
The system can't perform the operation now. Try again later.
Articles 1–20